These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


870 related items for PubMed ID: 19522736

  • 1. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
    Girgert R, Hanf V, Emons G, Gründker C.
    J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
    [Abstract] [Full Text] [Related]

  • 2. Signal transduction of the melatonin receptor MT1 is disrupted in breast cancer cells by electromagnetic fields.
    Girgert R, Hanf V, Emons G, Gründker C.
    Bioelectromagnetics; 2010 Apr; 31(3):237-45. PubMed ID: 19882681
    [Abstract] [Full Text] [Related]

  • 3. Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines.
    Lai L, Yuan L, Cheng Q, Dong C, Mao L, Hill SM.
    Breast Cancer Res Treat; 2009 Nov; 118(2):293-305. PubMed ID: 18979234
    [Abstract] [Full Text] [Related]

  • 4. Tracking the elusive antiestrogenic effect of melatonin: a new methodological approach.
    Girgert R, Bartsch C, Hill SM, Kreienberg R, Hanf V.
    Neuro Endocrinol Lett; 2003 Dec; 24(6):440-4. PubMed ID: 15073572
    [Abstract] [Full Text] [Related]

  • 5. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S, Krishnan AV, Feldman D.
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [Abstract] [Full Text] [Related]

  • 6. Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation.
    Jawed S, Kim B, Ottenhof T, Brown GM, Werstiuk ES, Niles LP.
    Eur J Pharmacol; 2007 Mar 29; 560(1):17-22. PubMed ID: 17303109
    [Abstract] [Full Text] [Related]

  • 7. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1.
    Chen C, Chang YC, Liu CL, Chang KJ, Guo IC.
    Breast Cancer Res Treat; 2006 Jul 29; 98(2):121-32. PubMed ID: 16752079
    [Abstract] [Full Text] [Related]

  • 8. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
    Lapillonne H, Konopleva M, Tsao T, Gold D, McQueen T, Sutherland RL, Madden T, Andreeff M.
    Cancer Res; 2003 Sep 15; 63(18):5926-39. PubMed ID: 14522919
    [Abstract] [Full Text] [Related]

  • 9. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
    Gery S, Tanosaki S, Bose S, Bose N, Vadgama J, Koeffler HP.
    Clin Cancer Res; 2005 May 01; 11(9):3184-90. PubMed ID: 15867211
    [Abstract] [Full Text] [Related]

  • 10. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J.
    Clin Cancer Res; 2005 Jun 15; 11(12):4357-64. PubMed ID: 15958618
    [Abstract] [Full Text] [Related]

  • 11. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
    Treeck O, Lattrich C, Springwald A, Ortmann O.
    Breast Cancer Res Treat; 2010 Apr 15; 120(3):557-65. PubMed ID: 19434490
    [Abstract] [Full Text] [Related]

  • 12. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
    Kinoshita Y, Chen S.
    Cancer Res; 2003 Jul 01; 63(13):3546-55. PubMed ID: 12839940
    [Abstract] [Full Text] [Related]

  • 13. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer.
    Ghosh MG, Thompson DA, Weigel RJ.
    Cancer Res; 2000 Nov 15; 60(22):6367-75. PubMed ID: 11103799
    [Abstract] [Full Text] [Related]

  • 14. Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines.
    Treeck O, Haldar C, Ortmann O.
    Oncol Rep; 2006 Jan 15; 15(1):231-5. PubMed ID: 16328061
    [Abstract] [Full Text] [Related]

  • 15. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
    Gudas JM, Klein RC, Oka M, Cowan KH.
    Clin Cancer Res; 1995 Feb 15; 1(2):235-43. PubMed ID: 9815978
    [Abstract] [Full Text] [Related]

  • 16. Sex hormone-binding globulin selectively modulates estradiol-regulated genes in MCF-7 cells.
    Catalano MG, Costantino L, Frairia R, Boccuzzi G, Fortunati N.
    Horm Metab Res; 2007 Apr 15; 39(4):288-94. PubMed ID: 17447168
    [Abstract] [Full Text] [Related]

  • 17. Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions.
    Suzuki T, Hayashi S, Miki Y, Nakamura Y, Moriya T, Sugawara A, Ishida T, Ohuchi N, Sasano H.
    Endocr Relat Cancer; 2006 Mar 15; 13(1):233-50. PubMed ID: 16601291
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells.
    Dubik D, Dembinski TC, Shiu RP.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6517-21. PubMed ID: 3677090
    [Abstract] [Full Text] [Related]

  • 19. Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression.
    Perera CN, Chin HG, Duru N, Camarillo IG.
    J Endocrinol; 2008 Nov 15; 199(2):221-33. PubMed ID: 18715880
    [Abstract] [Full Text] [Related]

  • 20. Functional interaction of fibroblast growth factor-8, bone morphogenetic protein and estrogen receptor in breast cancer cell proliferation.
    Masuda H, Otsuka F, Matsumoto Y, Takano M, Miyoshi T, Inagaki K, Shien T, Taira N, Makino H, Doihara H.
    Mol Cell Endocrinol; 2011 Aug 22; 343(1-2):7-17. PubMed ID: 21664418
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 44.